REBECCA Real-world Early BrEast CanCer mAnagement

Last updated: May 5, 2025
Sponsor: AstraZeneca
Overall Status: Active - Recruiting

Phase

N/A

Condition

Breast Cancer

Cancer

Treatment

N/A

Clinical Study ID

NCT06856343
D0817R00068
  • Ages > 18
  • All Genders

Study Summary

This is a French observational, national, multicenter prospective cohort study of patients with HER2-negative eBC treated with olaparib at their physician's discretion.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Male or female aged ≥ 18 years

  • Patient diagnosed with HER2-negative eBC

  • Patient about to be initiated with adjuvant Olaparib at their physician's discretion

  • Patient has been informed and does not object to participation in the study.

Exclusion

Exclusion Criteria:

  • Patient not consenting to participate.

  • Patients included in the Early Access Program

Study Design

Total Participants: 126
Study Start date:
December 30, 2024
Estimated Completion Date:
January 31, 2028

Study Description

The purpose to this observational study is to evaluate the rate of completion of adjuvant Olaparib treatment for HER2-negative early breast cancer patients in France.

Connect with a study center

  • Research Site

    Beauvais Cedex,
    France

    Site Not Available

  • Research Site

    Caen,
    France

    Site Not Available

  • Research Site

    Chambray Les Tours,
    France

    Active - Recruiting

  • Research Site

    Dechy,
    France

    Site Not Available

  • Research Site

    Frejus Cedex,
    France

    Site Not Available

  • Research Site

    Grenoble,
    France

    Site Not Available

  • Research Site

    Le Blanc Mesnil,
    France

    Site Not Available

  • Research Site

    Lille Cedex,
    France

    Site Not Available

  • Research Site

    Limoges Cedex 1,
    France

    Site Not Available

  • Research Site

    Metz Tessy,
    France

    Site Not Available

  • Research Site

    Montpellier,
    France

    Site Not Available

  • Research Site

    Nice Cedex 2,
    France

    Site Not Available

  • Research Site

    Poitiers Cedex,
    France

    Site Not Available

  • Research Site

    Rouen Cedex,
    France

    Active - Recruiting

  • Research Site

    St Gregoire Cedex,
    France

    Site Not Available

  • Research Site

    St Martin Boulogne,
    France

    Site Not Available

  • Research Site

    St Pierre Cedex,
    France

    Site Not Available

  • Research Site

    Thonon les bains,
    France

    Site Not Available

  • Research Site

    Valence Cedex 9,
    France

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.